Latest BioPharma News and In-Depth Analysis

Astellas and Roche Diabetes Care Japan Join Forces to Develop and Commercialize BlueStar®, an Integrated Diabetes Self-Management Solution

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it has entered into an agreement ("the Agr...

March 29, 2023 | Wednesday | News

Vertex and CRISPR Therapeutics Team Up for Hypoimmune Cell Therapy Development for Type 1 Diabetes

Vertex to receive non-exclusive rights to CRISPR Therapeutics’ CRISPR/Cas9 to accelerate development of potentially curative cell therapies for T1D- ...

March 28, 2023 | Tuesday | News

Exactech Boosts AI Capabilities with Exclusive Machine-Learning Software Licensing Agreement and Data Scientist Team

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today it has ex...

March 28, 2023 | Tuesday | News

Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets

Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a st...

January 24, 2023 | Tuesday | News

Zeon Corporation Acquires Edge Precision Manufacturing Inc ("Edge"), a leading manufacturer of micro featured thermoplastic devices for diagnostic, clinical, optics, and research applications

Zeon Corporation (Zeon; head office: Chiyoda-ku, Tokyo; President and CEO: Kimiaki Tanaka), through its subsidiary Zeon Specialty Materials Inc. (Californi...